French biotech Osivax was granted 30 million euros in public funding for the development of a universal vaccine against both influenza and coronavirus. With 21 GMP certified depots located around the world, including Europe, Yourway provides all customers with quality assurance and is focused on regulatory compliance--this is crucial when testing a vaccine around the world.